Agricultural Biotech

ITIF provides suggestions for FDA on how they can best implement the GMO education outreach mandated by Congress.
Agricultural Biotech
Check a box to narrow search for individual content items that cover numerous issues.
April 3, 2018
USDA has announced they will not regulate products of gene editing if they could also be produced by conventional breeding. This makes sense but doesn't go far enough writes Val Giddings in Innovation Files.
March 21, 2018
GMOs can save civilization by addressing the major challenges of food security, carbon emissions, and environmental stewardship in a way that benefits farmers, consumers, and biodiversity writes Val Giddings in Innovation Files.
November 12, 2017
ITIF provides suggestions for FDA on how they can best implement the GMO education outreach mandated by Congress.
August 15, 2017
In comments to the U.S. Department of Agriculture regarding the National Bioengineered Food Disclosure Standard, ITIF recommends how best to implement the congressionally mandated "GMO" disclosure.
July 12, 2017
For years, researchers have been developing genetic-engineering techniques to combat some of our most critical global challenges. Join ITIF for a discussion of these technologies, their promising applications, and the societal as well as policy challenges and opportunities they present.
June 14, 2017
ITIF submitted comments to the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service on its proposed revisions to regulations governing crops improved through biotechnology.
June 14, 2017
ITIF submitted comments to the Food and Drug Administration on how they should regulate foods derived from gene-edited plants.
May 30, 2017
ITIF submitted comments to the U.S. Environmental Protection Agency (EPA) on proposed regulations for RNA interference, or RNAi.
May 10, 2017
ITIF submitted comments to the U.S. Department of Agriculture on Cornell University’s request for permission to test a safe, promising pest control method.
April 17, 2017
ITIF submitted comments to the Food and Drug Administration on a proposal to treat gene-edited animals as forbidden until proven safe even in complete absence of any apparent risk.

Pages